ExploreInsights

Team announcement

Aspen Technology appoints David Leitham as Senior Vice President and General Manager

Aspen Technology appoints David Leitham as Senior Vice President and General Manager, Aspen Technology

Aspen Technology, Inc., a global leader asset optimization software, has announced that David Leitham will serve as new Senior Vice President and General Manager.

Leitham joins as part of an effort to bolster and propel the company’s pharmaceutical industry growth strategy. AspenTech is a global leader in asset optimization software, and has trained its growth objectives on the pharmaceutical space. Leitham will shape the product and solution strategy and lead go-to-market efforts.

“We believe that the pharmaceutical industry can continue to benefit from AspenTech’s current solution portfolio as it increases focus on operational excellence and accelerates its digitalization journey in manufacturing and across the enterprise. We see a significant opportunity to contribute to compliance with the regulatory requirements pharmaceutical companies must meet and to the value creation opportunities available through their ongoing digitalization efforts. Bringing David on board is an important step in helping them achieve these important objectives,” said Antonio Pietri, President and Chief Executive Officer of AspenTech.

Leitham boasts more than a quarter century of experience in the pharmaceutical industry, and should be able to lend an insider’s eye to AspenTech’s ambitions. Most recently, he served as Vice President and General Manager for Thermo Fisher Scientific, where he led a team that consistently delivered double-digit growth in software revenue. He has also held leadership roles at GlaxoSmithKline, The Network Connection, and FAAC Incorporated.

“AspenTech has an unrivaled reputation in the process manufacturing industries,” said Leitham. “That reputation has been earned through a relentless focus on meeting the needs of its customers, which I have long shared, and I am looking forward to enhancing that approach, along with our technology and expertise, to the pharmaceutical industry.”

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.